We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Proposed changes to the statutory scheme to control the costs of branded health service medicines.
First published during the 2019 to 2022 Johnson Conservative government
Impact assessment evaluating the measures in the Medicines and Medical Devices Bill, and illustrative statutory instruments showing how powers in the bill may be used.
We are seeking views on a proposal to make Acnecide Face 5% w/w Gel and Acnecide Face Wash 5% w/w Gel available from general sales outlets.
The government's response to the Health and Social Care Committee's report.
We are asking for views on a new draft version on our guidance for users, carers and staff on the safe use of bed rails.
The Home Secretary has formally commissioned the Advisory Council on the Misuse of Drugs (ACMD) to conduct a longer-term review of cannabis-based products for medicinal use.
First published during the 2016 to 2019 May Conservative government
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
This consultation seeks views on proposed changes to the statutory scheme to control the costs of branded health medicines.
How the government will improve patient access to breakthrough technologies and treatments in response to recommendations by the AAR.
MHRA is asking for feedback on proposals to change the legal classification of Otrivine extra dual relief nasal spray solution from prescription only medicine (POM) to pharmacy only (P).
MHRA is asking for feedback on a proposal to simplify the information requirements for advertisements aimed at prescribers and suppliers of medicines.
This consultation welcomes views on proposals to revoke ‘The Clinical Thermometers (EEC Requirements) Regulations 1993’ by November 2014.
MHRA has published a business engagement assessment on Composite Coordination Collection (CCC).
The MHRA is seeking views on the proposal on the introduction of tell-and-do variations for a specific subset of parallel import licences.
The Department of Health and the MHRA are seeking views on this proposal by the European Commission.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).